HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,844 | +170.4% | 22,290 | +157.2% | 0.02% | +162.5% |
| Q4 2022 | $682 | -99.8% | 8,668 | +47.1% | 0.01% | +60.0% |
| Q3 2022 | $436,000 | -17.9% | 5,891 | -27.7% | 0.01% | -16.7% |
| Q2 2022 | $531,000 | -25.1% | 8,148 | -27.3% | 0.01% | +20.0% |
| Q1 2022 | $709,000 | -21.7% | 11,211 | -34.3% | 0.01% | 0.0% |
| Q4 2021 | $905,000 | -38.2% | 17,068 | -17.7% | 0.01% | -28.6% |
| Q3 2021 | $1,464,000 | +394.6% | 20,738 | +367.1% | 0.01% | +600.0% |
| Q2 2021 | $296,000 | -69.9% | 4,440 | -49.9% | 0.00% | -80.0% |
| Q1 2021 | $985,000 | -82.0% | 8,870 | -80.8% | 0.01% | -82.8% |
| Q4 2020 | $5,484,000 | +832.7% | 46,185 | +585.5% | 0.03% | +625.0% |
| Q3 2020 | $588,000 | +37.1% | 6,737 | +40.7% | 0.00% | 0.0% |
| Q2 2020 | $429,000 | -97.0% | 4,787 | -96.6% | 0.00% | -97.0% |
| Q1 2020 | $14,206,000 | +1227.7% | 142,543 | +1430.6% | 0.13% | +1230.0% |
| Q4 2019 | $1,070,000 | -22.9% | 9,313 | -15.4% | 0.01% | -9.1% |
| Q3 2019 | $1,388,000 | +123.9% | 11,007 | +113.5% | 0.01% | +175.0% |
| Q2 2019 | $620,000 | -57.3% | 5,156 | -69.0% | 0.00% | -69.2% |
| Q1 2019 | $1,453,000 | +27.2% | 16,606 | +45.4% | 0.01% | +30.0% |
| Q4 2018 | $1,142,000 | +197.4% | 11,418 | +240.8% | 0.01% | +233.3% |
| Q3 2018 | $384,000 | -60.2% | 3,350 | -68.9% | 0.00% | -66.7% |
| Q2 2018 | $966,000 | +15.4% | 10,771 | -5.8% | 0.01% | +28.6% |
| Q1 2018 | $837,000 | +137.1% | 11,440 | +88.0% | 0.01% | +133.3% |
| Q4 2017 | $353,000 | +11.7% | 6,086 | -13.7% | 0.00% | 0.0% |
| Q3 2017 | $316,000 | -32.5% | 7,052 | -38.9% | 0.00% | -25.0% |
| Q1 2017 | $468,000 | +0.2% | 11,537 | -10.6% | 0.00% | -20.0% |
| Q3 2016 | $467,000 | +336.4% | 12,899 | +400.5% | 0.01% | +400.0% |
| Q2 2015 | $107,000 | -80.9% | 2,577 | -82.8% | 0.00% | -66.7% |
| Q4 2014 | $560,000 | +87.9% | 14,958 | +63.5% | 0.00% | +200.0% |
| Q1 2014 | $298,000 | -24.0% | 9,150 | -6.9% | 0.00% | -50.0% |
| Q3 2013 | $392,000 | – | 9,826 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |